Literature DB >> 12933917

Mitochondria.

P F Chinnery1, E A Schon.   

Abstract

Following the discovery in the early 1960s that mitochondria contain their own DNA (mtDNA), there were two major advances, both in the 1980s: the human mtDNA sequence was published in 1981, and in 1988 the first pathogenic mtDNA mutations were identified. The floodgates were opened, and the 1990s became the decade of the mitochondrial genome. There has been a change of emphasis in the first few years of the new millennium, away from the "magic circle" of mtDNA and back to the nuclear genome. Various nuclear genes have been identified that are fundamentally important for mitochondrial homeostasis, and when these genes are disrupted, they cause autosomally inherited mitochondrial disease. Moreover, mitochondrial dysfunction plays an important role in the pathophysiology of several well established nuclear genetic disorders, such as dominant optic atrophy (mutations in OPA1), Friedreich's ataxia (FRDA), hereditary spastic paraplegia (SPG7), and Wilson's disease (ATP7B). The next major challenge is to define the more subtle interactions between nuclear and mitochondrial genes in health and disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933917      PMCID: PMC1738655          DOI: 10.1136/jnnp.74.9.1188

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  100 in total

1.  The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation.

Authors:  N J Newman; M T Lott; D C Wallace
Journal:  Am J Ophthalmol       Date:  1991-06-15       Impact factor: 5.258

2.  X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation.

Authors:  X D Bu; J I Rotter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.

Authors:  I J Holt; A E Harding; R K Petty; J A Morgan-Hughes
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

Review 4.  Mitochondrial genetics '98 is the bottleneck cracked?

Authors:  J Poulton; V Macaulay; D R Marchington
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

5.  Localization of the Wilson's disease protein product to mitochondria.

Authors:  S Lutsenko; M J Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.

Authors:  D C Wallace; G Singh; M T Lott; J A Hodge; T G Schurr; A M Lezza; L J Elsas; E K Nikoskelainen
Journal:  Science       Date:  1988-12-09       Impact factor: 47.728

7.  Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes.

Authors:  P F Chinnery; N Howell; R N Lightowlers; D M Turnbull
Journal:  Brain       Date:  1997-10       Impact factor: 13.501

8.  Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice.

Authors:  N G Larsson; J Wang; H Wilhelmsson; A Oldfors; P Rustin; M Lewandoski; G S Barsh; D A Clayton
Journal:  Nat Genet       Date:  1998-03       Impact factor: 38.330

Review 9.  Leber hereditary optic neuropathy: mitochondrial mutations and degeneration of the optic nerve.

Authors:  N Howell
Journal:  Vision Res       Date:  1997-12       Impact factor: 1.886

10.  Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle.

Authors:  S L Old; M A Johnson
Journal:  Histochem J       Date:  1989 Sep-Oct
View more
  48 in total

1.  Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain.

Authors:  Gislaine Z Réus; Roberto B Stringari; Gislaine T Rezin; Daiane B Fraga; Juliana F Daufenbach; Giselli Scaini; Joana Benedet; Natália Rochi; Emílio L Streck; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-09-28       Impact factor: 3.575

2.  Successful TAT-mediated enzyme replacement therapy in a mouse model of mitochondrial E3 deficiency.

Authors:  Matan Rapoport; Lina Salman; Ofra Sabag; Mulchand S Patel; Haya Lorberboum-Galski
Journal:  J Mol Med (Berl)       Date:  2010-11-16       Impact factor: 4.599

3.  Mitochondrial DNA spectra of single human CD34+ cells, T cells, B cells, and granulocytes.

Authors:  Yoji Ogasawara; Kazutaka Nakayama; Magdalena Tarnowka; J Philip McCoy; Sachiko Kajigaya; Barbara C Levin; Neal S Young
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

4.  Shy1 couples Cox1 translational regulation to cytochrome c oxidase assembly.

Authors:  David U Mick; Karina Wagner; Martin van der Laan; Ann E Frazier; Inge Perschil; Magdalena Pawlas; Helmut E Meyer; Bettina Warscheid; Peter Rehling
Journal:  EMBO J       Date:  2007-09-20       Impact factor: 11.598

5.  TAT opens the door.

Authors:  Piyush M Vyas; Ronald M Payne
Journal:  Mol Ther       Date:  2008-04       Impact factor: 11.454

Review 6.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

7.  Ocular motility and Wilson's disease: a study on 34 patients.

Authors:  I Ingster-Moati; E Bui Quoc; M Pless; R Djomby; C Orssaud; J P Guichard; F Woimant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-30       Impact factor: 10.154

Review 8.  Cell death and survival through the endoplasmic reticulum-mitochondrial axis.

Authors:  R Bravo-Sagua; A E Rodriguez; J Kuzmicic; T Gutierrez; C Lopez-Crisosto; C Quiroga; J Díaz-Elizondo; M Chiong; T G Gillette; B A Rothermel; S Lavandero
Journal:  Curr Mol Med       Date:  2013-02       Impact factor: 2.222

Review 9.  Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.

Authors:  Pradip K Kamat; Anuradha Kalani; Philip Kyles; Suresh C Tyagi; Neetu Tyagi
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

10.  Possible involvement of a mitochondrial translation initiation factor 3 variant causing decreased mRNA levels in Parkinson's disease.

Authors:  Anna Anvret; Caroline Ran; Marie Westerlund; Ann-Christin Thelander; Olof Sydow; Charlotta Lind; Anna Håkansson; Hans Nissbrandt; Dagmar Galter; Andrea Carmine Belin
Journal:  Parkinsons Dis       Date:  2010-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.